[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335228-105":59,"doc-detail-335228-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gastric-cancer-and-intestinal-metaplasia-differential-metabolic-landscapes-and-new-pathways-to-diagnosis","Gastric Cancer and Intestinal Metaplasia - Differential Metabolic Landscapes and New Pathways to Diagnosis","","Gastric cancer is a leading cause of cancer-related mortality worldwide, and improving outcomes depends on early detection. Yet gastric-cancer specific biomarkers remain limited. This study compares intestinal metaplasia and gastric cancer metabolism using ultra-performance liquid chromatography-tandem mass spectrometry on samples from 37 patients. Metabolic profiling identifies extensive significant features and clear separation between conditions, highlighting altered pathways including steroid hormone biosynthesis, tryptophan, purine, and arginine/proline metabolism. Stage-related metabolite increases support six candidate diagnostic biomarkers, requiring further validation for noninvasive diagnosis and targeted therapy development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gastric-cancer-and-intestinal-metaplasia-differential-metabolic-landscapes-and-new-pathways-to-diagnosis/335228/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gastric-cancer-and-intestinal-metaplasia-differential-metabolic-landscapes-and-new-pathways-to-diagnosis/335228.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological comparison does the study focus on?","Question",{"text":112,"@type":113},"The study compares intestinal metaplasia (IM) and gastric cancer (GC) to determine metabolic differences and the pathways involved in GC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were metabolic differences measured?",{"text":117,"@type":113},"Metabolic analysis was performed using ultra-performance liquid chromatography with tandem mass spectrometry on tissue samples from 37 GC patients.",{"name":119,"@type":110,"acceptedAnswer":120},"Which pathways were most significantly altered between IM and GC?",{"text":121,"@type":113},"The most significantly altered pathways included steroid hormone biosynthesis, tryptophan metabolism, purine metabolism, and arginine and proline metabolism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335228,1790161605,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nGastric Cancer and Intestinal Metaplasia: Differential Metabolic Landscapes and New Pathways to Diagnosis  \nSeong Ji Choi 1,2,†, Hyuk Soon Choi 2,†, Hyunil Kim 3, Jae Min Lee 2, Seung Han Kim 2, Jai Hoon Yoon 1, Bora Keum 2, Hyo Jung Kim 2, Hoon Jai Chun 2,* and Youngja H. Park 3, *  \nCitation: Choi, S.J.; Choi, H.S.; Kim, H.; Lee, J.M.; Kim, S.H.; Yoon, J.H.; Keum, B.; Kim, H.J.; Chun, H.J.; Park, Y.H. Gastric Cancer and Intestinal Metaplasia: Differential Metabolic Landscapes and New Pathways to Diagnosis. Int. J. Mol. Sci. 2024, 25, 9509. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25179509  \nAcademic Editor: Nam Deuk Kim  \nReceived: 30 June 2024  \nRevised: 16 August 2024  \nAccepted: 19 August 2024  \nPublished: 1 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Internal Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea; [drcoolandy@gmail.com](drcoolandy@gmail.com) (S.J.C.); [jaihoonyoon@hanyang.ac.kr](jaihoonyoon@hanyang.ac.kr) (J.H.Y.)  \n2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea; [mdkorea@gmail.com](mdkorea@gmail.com) (H.S.C.); [jmlee1202@gmail.com](jmlee1202@gmail.com) (J.M.L.); [kimseunghan09@gmail.com](kimseunghan09@gmail.com) (S.H.K.); [borakeum@hanmail.net](borakeum@hanmail.net) (B.K.); [hjkimmd@korea.ac.kr](hjkimmd@korea.ac.kr) (H.J.K.)  \n3 EN BIO, Cheongju-si 28494, Republic of Korea; [kimhyunil7071@gmail.com](kimhyunil7071@gmail.com)  \n* [Correspondence: hjchan@korea.ac.kr](Correspondence: hjchan@korea.ac.kr) (H.J.C.); [youngja.hwang@en-bio.com](youngja.hwang@en-bio.com) (Y.H.P.); Tel.: +82-43-217-1357 (Y.H.P.)  \n† These authors equally contributed to this work as co-first.  \nAbstract: Gastric cancer (GC) is the fifth most common cause of cancer-related death worldwide. Early detection is crucial for improving survival rates and treatment outcomes. However, accurate GC-specific biomarkers remain unknown. This study aimed to identify the metabolic differences between intestinal metaplasia (IM) and GC to determine the pathways involved in GC. A metabolic analysis of IM and tissue samples from 37 patients with GC was conducted using ultra-performance liquid chromatography with tandem mass spectrometry. Overall, 665 and 278 significant features were identified in the aqueous and 278 organic phases, respectively, using false discovery rate analysis, which controls the expected proportion of false positives among the significant results. sPLS-DA revealed a clear separation between IM and GC samples. Steroid hormone biosynthesis, tryptophan metabolism, purine metabolism, and arginine and proline metabolism were the most significantly altered pathways. The intensity of 11 metabolites, including N1, N2-diacetylspermine, creatine riboside, and N-formylkynurenine, showed significant elevation in more advanced GC. Based on pathway enrichment analysis and cancer stage-specific alterations, we identified six potential candidates as diagnostic biomarkers: aldosterone, N-formylkynurenine, guanosine triphosphate, arginine, S-adenosylmethioninamine, and creatine riboside. These metabolic differences between IM and GC provide valuable insights into gastric carcinogenesis. Further validation is needed to develop noninvasive diagnostic tools and targeted therapies to improve the outcomes of patients with GC.  \nKeywords: gastric cancer; intestinal metaplasia; metabolomics; metabolite profiling; biomarker  \n1. Introduction  \nGastric cancer (GC) is the fifth most common cancer type and the fifth leading cause of can","cbCailc5ad443ZPG","https://ap.wps.com/l/cbCailc5ad443ZPG","pdf",4588354,17,"English","# Introduction\n## Rationale and clinical need for early detection\n## Limitations of current diagnostic approaches and biomarkers\n# Methods and data analysis\n## Metabolic profiling using UPLC-MS/MS\n## Statistical analysis and pathway enrichment\n# Results\n## Differential metabolic features and separation between conditions\n## Altered pathways\n## Stage-specific metabolite elevation and diagnostic candidates","[{\"question\":\"What biological comparison does the study focus on?\",\"answer\":\"The study compares intestinal metaplasia (IM) and gastric cancer (GC) to determine metabolic differences and the pathways involved in GC.\"},{\"question\":\"How were metabolic differences measured?\",\"answer\":\"Metabolic analysis was performed using ultra-performance liquid chromatography with tandem mass spectrometry on tissue samples from 37 GC patients.\"},{\"question\":\"Which pathways were most significantly altered between IM and GC?\",\"answer\":\"The most significantly altered pathways included steroid hormone biosynthesis, tryptophan metabolism, purine metabolism, and arginine and proline metabolism.\"}]","Gastric Cancer and Intestinal Metaplasia - Differential Metabolic Landscapes and New Pathways to Diagnosis | PDF",1790010219,43]